BRIEF published on 08/04/2025 at 10:55, 9 months 2 days ago Sartorius Stedim Biotech: Number of shares and voting rights Share Capital Voting Rights Actions AMF Sartorius Stedim Biotech
BRIEF published on 08/04/2025 at 10:55, 9 months 2 days ago Sartorius Stedim Biotech : Nombre d'actions et de droits de vote Droits De Vote Capital Social Actions AMF Sartorius Stedim Biotech
PRESS RELEASE published on 08/04/2025 at 10:50, 9 months 2 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE AU NOMBRE D’ACTIONS ET DE DROITS DE VOTE COMPOSANT LE CAPITAL SOCIAL Déclaration du nombre d'actions et de droits de vote de Sartorius Stedim Biotech SA. Informations réglementaires du 04-Aou-2025 Déclaration Droits De Vote Capital Social Sartorius Stedim Biotech SA Réglementaire
PRESS RELEASE published on 08/04/2025 at 10:50, 9 months 2 days ago Sartorius Stedim Biotech SA: DECLARATION RELATIVE TO THE NUMBER OF SHARES AND VOTING RIGHTS MAKING UP THE ISSUED CAPITAL Sartorius Stedim Biotech SA: Declaration of the number of shares and voting rights in the issued capital as of July 31, 2025 Voting Rights Déclaration Shares Sartorius Stedim Biotech Issued Capital
BRIEF published on 07/22/2025 at 07:07, 9 months 15 days ago Sartorius Stedim Biotech Releases H1 2025 Financial Report Business Development Biopharmaceutical Industry Half-year Results Sartorius Stedim 2025 Financial Report
BRIEF published on 07/22/2025 at 07:07, 9 months 15 days ago Sartorius Stedim Biotech publie son rapport financier du premier semestre 2025 Résultats Semestriels Industrie Biopharmaceutique Développement Des Affaires Sartorius Stedim Rapport Financier 2025
BRIEF published on 07/22/2025 at 07:05, 9 months 15 days ago Sartorius Stedim Biotech annonce de solides résultats pour le premier semestre 2025 Rentabilité Sartorius Stedim Biotech Croissance Des Ventes Industrie Biopharmaceutique Résultats Semestriels 2025
BRIEF published on 07/22/2025 at 07:05, 9 months 15 days ago Sartorius Stedim Biotech Reports Solid Half-Year 2025 Results Profitability Sales Growth Sartorius Stedim Biotech Biopharmaceutical Industry Half-year Results 2025
PRESS RELEASE published on 07/22/2025 at 07:02, 9 months 15 days ago Sartorius Stedim Biotech SA: Communiqué de mise à disposition de documents Sartorius Stedim Biotech SA communique les résultats du premier semestre 2025 et les prévisions pour l'année 2025. Informations disponibles sur leur site Investor Relations Documents Résultats Premier Semestre Sartorius Stedim Biotech SA
PRESS RELEASE published on 07/22/2025 at 07:02, 9 months 15 days ago Sartorius Stedim Biotech SA: Information on Document Availability Sartorius Stedim Biotech SA releases first half 2025 results and full year forecast. Report available online with financial statements and company profile Financial Statements Investor Relations Sartorius Stedim Biotech Biopharmaceutical Industry First Half 2025 Results
Published on 05/07/2026 at 02:00, 29 minutes ago Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 2 hours 59 minutes ago Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 3 hours 24 minutes ago Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 3 hours 29 minutes ago Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance
Published on 05/06/2026 at 22:10, 4 hours 19 minutes ago Banyan Gold Announces Closing of $46.5 Million Private Placement
Published on 05/07/2026 at 00:47, 1 hour 42 minutes ago Blue Cap AG expands portfolio through the acquisition of Janoschka AG
Published on 05/07/2026 at 00:43, 1 hour 46 minutes ago EQS-Adhoc: Blue Cap AG Acquires Janoschka AG and Adjusts Forecast Due to Transaction
Published on 05/06/2026 at 20:32, 5 hours 57 minutes ago EQS-Adhoc: Kontron AG: ADHOC Kontron AG / Potential Public Takeover Bid by Ennoconn Corporation
Published on 05/06/2026 at 20:22, 6 hours 7 minutes ago EQS-Adhoc: ams-OSRAM AG: ams OSRAM delivers strong Q1 results, enters AI market through a development agreement with a leading AI photonics customer and sees path to positive Free Cash Flow in 2027
Published on 05/06/2026 at 19:18, 7 hours 11 minutes ago Fuller, Smith & Turner PLC: Transaction in own shares
Published on 05/06/2026 at 18:00, 8 hours 29 minutes ago Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 8 hours 29 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 8 hours 29 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 18:00, 8 hours 29 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026
Published on 05/06/2026 at 17:45, 8 hours 44 minutes ago Information concerning the total number of voting rights and shares 2026 04 30
